Interesting conclusions were also drawn from other researches; Li et al. [75] found increased expression of FoxP3 on regulatory cells, in patients prior to treatment of acute lymphoblastic leukemia, in relation to healthy volunteers, and patients in a remission of the disease. The gene discussed is FOXP3; the disease is acute lymphoblastic leukemia.